Literature DB >> 10871767

Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells.

W Choe1, A Albright, J Sulcove, S Jaffer, J Hesselgesser, E Lavi, P Crino, D L Kolson.   

Abstract

APJ is a recently described seven-transmembrane (7TM) receptor that is abundantly expressed in the central nervous system (CNS). This suggests an important role for APJ in neural development and/or function, but neither its cellular distribution nor its function have been defined. APJ can also serve as a co-receptor with CD4 for fusion and infection by some strains of human immunodeficiency virus (HIV-1) in vitro, suggesting a role in HIV neuropathogenesis if it were expressed on CD4-positive CNS cells. To address this, we examined APJ expression in cultured neurons, astrocytes, oligodendrocytes, microglia and monocyte-derived macrophages utilizing both immunocytochemical staining with a polyclonal anti-APJ antibody and RT - PCR. We also analyzed the ability of a recently identified APJ peptide ligand, apelin, to induce calcium elevations in cultured neural cells. APJ was expressed at a high level in neurons and oligodendrocytes, and at lower levels in astrocytes. In contrast, APJ was not expressed in either primary microglia or monocyte-derived macrophages. Several forms of the APJ peptide ligand induced calcium elevations in neurons. Thus, APJ is selectively expressed in certain CNS cell types and mediates intracellular signals in neurons, suggesting that APJ may normally play a role in signaling in the CNS. However, the absence of APJ expression in microglia and macrophages, the prinicpal CD4-positive cell types in the brain, indicates that APJ is unlikely to mediate HIV-1 infection in the CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871767

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  25 in total

1.  Apelin-13 attenuates traumatic brain injury-induced damage by suppressing autophagy.

Authors:  Hai-Jun Bao; Lin Zhang; Wen-Can Han; Ding-Kun Dai
Journal:  Neurochem Res       Date:  2014-11-02       Impact factor: 3.996

Review 2.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

3.  Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons.

Authors:  S B Oh; P B Tran; S E Gillard; R W Hurley; D L Hammond; R J Miller
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

4.  NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury.

Authors:  Denise R Cook; Amy J Gleichman; Stephanie A Cross; Shachee Doshi; Wenzhe Ho; Kelly L Jordan-Sciutto; David R Lynch; Dennis L Kolson
Journal:  J Neurochem       Date:  2011-08-08       Impact factor: 5.372

Review 5.  Vascular effects of apelin: Mechanisms and therapeutic potential.

Authors:  Amreen Mughal; Stephen T O'Rourke
Journal:  Pharmacol Ther       Date:  2018-05-25       Impact factor: 12.310

Review 6.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

7.  Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia.

Authors:  Mehdi Khaksari; Nahid Aboutaleb; Farinaz Nasirinezhad; Abedin Vakili; Zahra Madjd
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

8.  Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons.

Authors:  Xiang Jun Zeng; Shan Ping Yu; Like Zhang; Ling Wei
Journal:  Exp Cell Res       Date:  2010-02-10       Impact factor: 3.905

9.  Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.

Authors:  Hyung J Chun; Ziad A Ali; Yoko Kojima; Ramendra K Kundu; Ahmad Y Sheikh; Rani Agrawal; Lixin Zheng; Nicholas J Leeper; Nathan E Pearl; Andrew J Patterson; Joshua P Anderson; Philip S Tsao; Michael J Lenardo; Euan A Ashley; Thomas Quertermous
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

10.  Simian fetal brain progenitor cells for studying viral neuropathogenesis.

Authors:  Naoko Iwata; Hiroaki Yoshida; Minoru Tobiume; Fumiko Ono; Takuya Shimazaki; Tetsutaro Sata; Noriko Nakajima
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.